These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 30353757)

  • 1. Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.
    Nishio M; Ishii Y; Hashimoto Y; Otake H; Ogashiwa T; Tsuda S; Yasuhara H; Saigusa Y; Kimura H; Maeda S; Kunisaki R
    Scand J Gastroenterol; 2018; 53(10-11):1236-1244. PubMed ID: 30353757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
    Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
    J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.
    Nasuno M; Miyakawa M; Tanaka H; Motoya S
    Digestion; 2017; 95(1):67-71. PubMed ID: 28052276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
    Pellet G; Stefanescu C; Carbonnel F; Peyrin-Biroulet L; Roblin X; Allimant C; Nachury M; Nancey S; Filippi J; Altwegg R; Brixi H; Fotsing G; de Rosamel L; Shili S; Laharie D;
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):494-501. PubMed ID: 30213584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice.
    Sugimoto K; Ikeya K; Kato M; Matsuura A; Watanabe F; Takano R; Tamura S; Tani S; Osawa S; Hanai H
    Dig Dis; 2019; 37(1):11-20. PubMed ID: 30205400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice.
    Bálint A; Farkas K; Palatka K; Lakner L; Miheller P; Rácz I; Hegede G; Vincze Á; Horváth G; Szabó A; Nagy F; Szepes Z; Gábor Z; Zsigmond F; Zsóri Á; Juhász M; Csontos Á; Szűcs M; Bor R; Milassin Á; Rutka M; Molnár T
    J Crohns Colitis; 2016 Jan; 10(1):26-30. PubMed ID: 26392413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
    Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
    World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
    Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
    Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis.
    Zhao HN; Jiang M; Sun MJ; Dai C
    Saudi J Gastroenterol; 2021; 27(4):191-200. PubMed ID: 34380865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres.
    Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL
    J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study.
    Ma C; Beilman CL; Huang VW; Fedorak DK; Wong K; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
    Can J Gastroenterol Hepatol; 2016; 2016():2079582. PubMed ID: 27478817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
    Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
    World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
    Taxonera C; Barreiro-de Acosta M; Calvo M; Saro C; Bastida G; Martín-Arranz MD; Gisbert JP; García-Sánchez V; Marín-Jiménez I; Bermejo F; Chaparro M; Ponferrada Á; Martínez-Montiel MP; Pajares R; de Gracia C; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
    Dig Dis Sci; 2015 Oct; 60(10):3075-84. PubMed ID: 26044830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.
    Molnár T; Farkas K; Nyári T; Szepes Z; Nagy F; Wittmann T
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):359-63. PubMed ID: 22187700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Taxonera C; Iglesias E; Muñoz F; Calvo M; Barreiro-de Acosta M; Busquets D; Calvet X; Rodríguez A; Pajares R; Gisbert JP; López-Serrano P; Pérez-Calle JL; Ponferrada Á; De la Coba C; Bermejo F; Chaparro M; Olivares D; Alba C; Fernández-Blanco I
    Dig Dis Sci; 2017 Feb; 62(2):481-490. PubMed ID: 27995400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
    Tsukamoto H; Tanida S; Mizoshita T; Ozeki K; Ebi M; Shimura T; Mori Y; Kataoka H; Kamiya T; Joh T
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
    Llaó J; Naves JE; Ruiz-Cerulla A; Gordillo J; Mañosa M; Maisterra S; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
    Dig Liver Dis; 2016 Jun; 48(6):608-12. PubMed ID: 27012443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.